Overexpression of lipoic acid synthase gene alleviates diabetic nephropathy of Leprdb/db mice
Introduction Diabetic nephropathy (DN) develops in about 40% of patients with type 2 diabetes and remains the leading cause of end-stage renal disease. The mechanisms of DN remain to be elucidated. Oxidative stress is thought to be involved in the development of DN but antioxidant therapy has produc...
Main Authors: | Tingting Yan, Sanqiao Yao, Weidong Wu, Yingzheng Zhao, Cheng Xiong, Meiyu Chang, Qiyu Gao, Xianwen Yi, Guangcui Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/9/1/e002260.full |
Similar Items
-
Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy.
by: Longquan Xu, et al.
Published: (2016-01-01) -
A novel compound heterozygous leptin receptor mutation causes more severe obesity than in Leprdb/db mice
by: Claudia Berger, et al.
Published: (2021-01-01) -
Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.
by: Tomohiko Ohno, et al.
Published: (2015-01-01) -
Silk fibroin promotes the regeneration of pancreatic β-cells in the C57BL/KsJ-Leprdb/db mouse
by: Jun Hong Park, et al.
Published: (2020-01-01) -
Schistosoma japonicum Soluble Egg Antigen Protects Against Type 2 Diabetes in Leprdb/db Mice by Enhancing Regulatory T Cells and Th2 Cytokines
by: Chun-lian Tang, et al.
Published: (2019-06-01)